In Person Special Seminar: Involvement of Non-canonical Inflammatory Response in Tissue Dysfunction of Several Chronic Diseases
David Crossman, Ph.D.
Academic Director, Biomedical Research Imaging Unit
Senior Research Fellow, Heart Foundation of New Zealand
Cardiac Nanobiology Research Group
Department of Physiology
School of Medical Sciences
Waipapa Taumata Rau | The University of Auckland
In Person Seminar: Fibrosis and Aberrant Ca2+ Handling in the Failing Heart
Date: Feb. 15, 2024
Time: 11 a.m.
About this Seminar
Fibrosis and aberrant Ca2+ handling are hallmarks of heart failure but are considered separate features. However, the fibrotic disposition of nanometer-sized collagen fibrils, particularly collagen VI (ColVI), may directly diminish Ca2+signalling in human heart failure. Using super-resolution microscopy Dr. Crossman and his team found increased ColVI within the transverse(t)-tubules. Moreover, t-tubule remodeling disrupts Ca2+ signaling in heart failure. Recently, circulating levels of ColVI were found to independently associate with poor outcomes in heart failure. While the importance of ColVI to skeletal muscle function is underscored by its mutation causing muscular dystrophy, its role in cardiac contraction remains poorly understood. Significantly, muscular dystrophy patients often develop heart failure. To understand the role of ColVI in the heart the lab created a knockout of this gene in the rat (Col6a1-/-). Echocardiography showed both impaired systolic and diastolic function. Cardiac myocytes from Col6a1-/- have increased systolic Ca2+transient and greater response to b-adrenergic stimulation that is pro-arrhythmogenic. Similar disturbance in Ca2+ handling is found in the cardiac myocytes of the mdx mouse which has non-functional dystrophin supporting our hypothesis that ColVI is part of the dystrophin-glycoprotein-complex and may have a role in regulating Ca2+ dynamics.
You May Also Be Interested In...
-
Home Item
Development of Genome Editor Therapies for Angelman Syndrome , homeSept. 13, 2024, 11:00 a.m. | Mark J. Zylka, Ph.D., W.R. Kenan, Jr. Distinguished Professor, University of North Carolina at Chapel Hill; Director, UNC Neuroscience Center | Co-Sponsored by the Center for Neurobiology Research, Fralin Biomedical Research Institute
-
Home Item
Understanding the Limits of Exercise Responsiveness in Older Adults , homeSept. 20, 2024, 11:00 a.m. | Ian R. Lanza, Ph.D., Professor of Medicine, Mayo Clinic College of Medicine and Science | Co-Sponsored by the Center for Exercise Medicine Research, Fralin Biomedical Research Institute
-
Home Item
From Variant Functionality to Resistance in Cancer , homeSept. 27, 2024, 11:00 a.m. | Tiki Hayes, Ph.D., Assistant Professor, Department of Molecular and Medical Pharmacology, UCLA David Geffen School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – D.C.
-
Home Item
Disrupting Health Care Using Deep Data and Remote Monitoring , homeOct. 4, 2024, 11:00 a.m. | Michael Snyder, Ph.D., Professor, Genetics, Director, Center for Genomics and Personalized Medicine, Stanford Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Exercise Medicine Research
-
Home Item
Mechanisms of Longevity: From Mice to Whales , homeOct. 10, 2024, 5:30 p.m. (Reception at 5 p.m.) | Vera Gorbunova, Ph.D., Doris Johns Cherry Professor of Biology, Co-director, Rochester Aging Research Center, University of Rochester | Maury Strauss Distinguished Public Lecture
-
Home Item
Continuous Decision-Making , homeOct. 11, 2024, 11:00 a.m. | Benjamin Hayden, Ph.D., Professor and McNair Scholar of Neurosurgery, Baylor College of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Human Neuroscience Research